The safety and efficacy of compound using of etomidate and propofol in the elderly patients undergoing gastroscopy

The application of compound using of etomidate and propofol in the elderly patients undergoing gastroscopy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-13003924

Enrollment

Unknown

Registered

2013-09-16

Start date

2012-01-06

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pathological and physiological in elderly patients

Interventions

Group P:Propofol

Group E:Etomidate

Group P+E:propofol + etomidate

Group E+P:etomidate + propofol

Eligibility

Sex/Gender

All

Age

60 Years to 79 Years

Inclusion criteria

Inclusion criteria: A total of 200 healthy, ASA score II/III patients, consisted of 97 male and 103 female, aged from 60 to 79 years, and scheduled for gastroscopy with sedation, were enrolled in the study

Exclusion criteria

Exclusion criteria: severe dysfunction of heart, lung, liver, kidney; sleep apnea syndrome; gastric retention, a known history of allergy to the study drugs, a history of previous experience with endoscopy, or patients who were receiving other analgesics such as nonsteroidal anti-inflammatory drugs. Patients were receiving alpha-methyldopa, clonidine, or a beta-blocker; patients with a psychiatric disorder, neurological or neuromuscular disorders, or those who had used drug, alcohol, or tobacco two weeks before the study were also excluded

Design outcomes

Primary

Measure	Time frame
Vita signs;	—

Countries

China

Contacts

Public ContactZhongyuan Xia

Renmin Hospital of Wuhan University

xiazhongyuanmz@hotmail.com+86 13808628560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026